apricoxib

DRUG3 trials

Sponsors

Tragara Pharmaceuticals, Inc., University of Maryland, Baltimore, Jonsson Comprehensive Cancer Center

Conditions

Lung CancerMetastatic Pancreatic CancerNon Small Cell Lung CancerPancreatic Cancer

Phase 2

APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer

CompletedNCT00709826

Tragara Pharmaceuticals, Inc.Metastatic Pancreatic Cancer, Pancreatic Cancer

Start: 2008-08-31End: 2011-05-31Updated: 2012-11-07

0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer

CompletedNCT00771953

University of Maryland, BaltimoreLung Cancer, Non Small Cell Lung Cancer

Start: 2008-11-30End: 2014-12-31Updated: 2019-10-30

Unknown Phase

Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer

TerminatedNCT01532362

Jonsson Comprehensive Cancer CenterNon Small Cell Lung Cancer

Start: 2011-11-30End: 2012-05-31Updated: 2020-09-22